Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Samsara BioCapital, L.P. reported a 61.20% stake in Kalaris Therapeutics, Inc. (Schedule 13D)

Event Mar 18, 2025 · Filed Mar 25, 2025

Samsara BioCapital, L.P. reported a 61.20% stake in Kalaris Therapeutics, Inc., 11,448,081 shares, with active intent on Mar 18, 2025. Filed Mar 25, 2025 (Schedule 13D).

Stake
61.20%
Shares
11,448,081
Intent
Active
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.61.20%11,448,081
Samsara BioCapital GP, LLC61.20%11,448,081
Srinivas Akkaraju61.20%11,448,081

Source

View original at SEC

Related